95 related articles for article (PubMed ID: 9030908)
1. Inhibition by abruquinone A of phosphoinositide-specific phospholipase C activation in rat neutrophils.
Wang JP; Hsu MF; Kuo SC
Eur J Pharmacol; 1997 Jan; 319(1):131-6. PubMed ID: 9030908
[TBL] [Abstract][Full Text] [Related]
2. Impairment of phosphatidylinositol signaling in acetylshikonin-treated neutrophils.
Wang JP; Kuo SC
Biochem Pharmacol; 1997 Apr; 53(8):1173-7. PubMed ID: 9175722
[TBL] [Abstract][Full Text] [Related]
3. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
Hsu MF; Chang LC; Chen SC; Kuo SC; Lee HY; Lu MC; Wang JP
Eur J Pharmacol; 2008 Nov; 598(1-3):123-31. PubMed ID: 18834875
[TBL] [Abstract][Full Text] [Related]
4. U-73122, an aminosteroid phospholipase C inhibitor, may also block Ca2+ influx through phospholipase C-independent mechanism in neutrophil activation.
Wang JP
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):599-605. PubMed ID: 8738291
[TBL] [Abstract][Full Text] [Related]
5. Cellular localization of the inhibitory action of abruquinone A against respiratory burst in rat neutrophils.
Hsu MF; Raung SL; Tsao LT; Kuo SC; Wang JP
Br J Pharmacol; 1997 Mar; 120(5):917-25. PubMed ID: 9138699
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
[TBL] [Abstract][Full Text] [Related]
7. Activation of p38 mitogen-activated protein kinase by formyl-methionyl-leucyl-phenylalanine in rat neutrophils.
Chang LC; Wang JP
Eur J Pharmacol; 2000 Feb; 390(1-2):61-6. PubMed ID: 10708707
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by manoalide of fMLP-stimulated elastase release from human neutrophils.
De Vries GW; Amdahl LD; Kramer KD; Wheeler LA
Biochem Pharmacol; 1990 Dec; 40(11):2487-90. PubMed ID: 2268367
[TBL] [Abstract][Full Text] [Related]
9. Artocarpol A stimulation of superoxide anion generation in neutrophils involved the activation of PLC, PKC and p38 mitogen-activated PK signaling pathways.
Kuan YH; Lin RH; Tsao LT; Lin CN; Wang JP
Br J Pharmacol; 2005 Jun; 145(4):460-8. PubMed ID: 15806113
[TBL] [Abstract][Full Text] [Related]
10. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
Vickers JD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ signalling mechanisms of the beta 2 integrin on neutrophils: involvement of phospholipase C gamma 2 and Ins(1,4,5)P3.
Hellberg C; Molony L; Zheng L; Andersson T
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):403-9. PubMed ID: 8713065
[TBL] [Abstract][Full Text] [Related]
12. Nonselective effects of the putative phospholipase C inhibitor, U73122, on adenosine A1 receptor-mediated signal transduction events in Chinese hamster ovary cells.
Walker EM; Bispham JR; Hill SJ
Biochem Pharmacol; 1998 Dec; 56(11):1455-62. PubMed ID: 9827577
[TBL] [Abstract][Full Text] [Related]
13. In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions.
Hou C; Kirchner T; Singer M; Matheis M; Argentieri D; Cavender D
J Pharmacol Exp Ther; 2004 May; 309(2):697-704. PubMed ID: 14730005
[TBL] [Abstract][Full Text] [Related]
14. Magnolol induces cytosolic-free Ca2+ elevation in rat neutrophils primarily via inositol trisphosphate signalling pathway.
Wang JP; Chen CC
Eur J Pharmacol; 1998 Jul; 352(2-3):329-34. PubMed ID: 9716370
[TBL] [Abstract][Full Text] [Related]
15. Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil.
Bonser RW; Thompson NT; Randall RW; Tateson JE; Spacey GD; Hodson HF; Garland LG
Br J Pharmacol; 1991 May; 103(1):1237-41. PubMed ID: 1908735
[TBL] [Abstract][Full Text] [Related]
16. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils.
Chen LW; Lin MW; Hsu CM
J Biomed Sci; 2005; 12(2):311-9. PubMed ID: 15917990
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of calcium fluxes and calmodulin block activation of the p21-activated protein kinases in neutrophils.
Lian JP; Crossley L; Zhan Q; Huang R; Coffer P; Toker A; Robinson D; Badwey JA
J Immunol; 2001 Feb; 166(4):2643-50. PubMed ID: 11160327
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin stimulates phosphoinositide turnover and phospholipase C but not phospholipase D and NADPH oxidase in human neutrophils.
Catz SD; Steŕin-Speziale NB
J Leukoc Biol; 1996 Apr; 59(4):591-7. PubMed ID: 8613709
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phospholipase D activation by CYL-26z in formyl peptide-stimulated neutrophils involves the blockade of RhoA activation.
Kuan YH; Lin RH; Tsao LT; Chen YL; Tzeng CC; Wang JP
Biochem Pharmacol; 2005 Sep; 70(6):901-10. PubMed ID: 16024001
[TBL] [Abstract][Full Text] [Related]
20. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
Smith RJ; Sam LM; Justen JM; Bundy GL; Bala GA; Bleasdale JE
J Pharmacol Exp Ther; 1990 May; 253(2):688-97. PubMed ID: 2338654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
